Moral and policy issues in long-acting contraception

Annual Review of Public Health

Volumn 18, Issue , 1997, Pages 379-400

  Brown, George F ^a   Moskowitz, Ellen H ^b  

^a POPULATION COUNCIL   (United States)

^b HASTINGS CENTER   (United States)

Author keywords

contraceptive introduction; ethics; long acting contraception; moral issues; policy

Indexed keywords

ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT;

BIRTH CONTROL; CONTRACEPTION; DEVELOPING COUNTRY; ETHICS; FAMILY PLANNING; FEMALE STERILIZATION; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH PROGRAM; HUMAN; HUMAN RIGHTS; IMMUNOCONTRACEPTION; INTRAUTERINE CONTRACEPTIVE DEVICE; LONG TERM CARE; MORALITY; ORAL DRUG ADMINISTRATION; POLICY; PRIORITY JOURNAL; REVIEW; UNITED STATES; WORLD HEALTH ORGANIZATION;

AMERICAS; CONTRACEPTION; CONTRACEPTIVE IMPLANTS; CONTRACEPTIVE METHODS; CRITIQUE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; ETHICS; FAMILY PLANNING; FAMILY PLANNING POLICY; HUMAN RIGHTS; INJECTABLES; IUD; LITERATURE REVIEW; NORTH AMERICA; NORTHERN AMERICA; POLICY; POPULATION POLICY; SOCIAL POLICY; UNITED STATES;

CONTRACEPTION; DELAYED-ACTION PREPARATIONS; ETHICS, MEDICAL; FAMILY PLANNING SERVICES; FEMALE; HEALTH POLICY; HUMANS; MALE; POLITICS; UNITED STATES; WOMEN'S RIGHTS;

EID: 0030901564     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.publhealth.18.1.379     Document Type: Review

References (71)

1. Alexander NJ. 1996. Barriers to sexually transmitted diseases. In Science and Medicine. March/April 32-41. New York: Sci. Am.
2. Alexander NJ. 1994. Contraceptive vaccines. See Ref. 61a, pp. 203-14
3. American Medical Association, Board of Trustees. 1992. Requirements or incentives by government for the use of long-acting contraceptives. JAMA 267:1818-21
4. Arthur SL. 1992. The Norplant prescription: birth control, woman control, or crime control. UCLA Law Rev. 40:1-101
5. Deleted in proof
6. Beattie KJ, Brown GF. 1994. Expanding contraceptive choice: the Norplant experience. See Ref. 61a, pp. 263-79
7. Berelson B. 1964. Application of intrauterine contraception in family planning programs. In Intrauterine Contraception, ed. SJ Segal, AL Southam, KD Schafer, pp. 9-13. New York: Excerpta Medica Found.
8. BNA Health Law Reporter. 1994. Products liability case filed against U.S. makers of implanted contraceptive. Sept. 22, p. 1310
9. Boston Women's Health Book Collective. 1992. The New Our Bodies, Ourselves, pp. 13-16. New York: Simon & Schuster
10. Boston Women's Health Book Collective. 1992. See Ref. 9, pp. 279-80
11. Brown GF. 1987. Family planning programs. In Technology in Society, ed. G Zeidenstein, pp. 465-80. New York: Pergamon
12. Bruce J. 1990. Fundamental elements of the quality of care: a simple framework. Stud. Fam. Plan. 21(2):61-91
13. Buck v. Bell. 1927. 274 U.S. 200
14. Chesler E. 1992. Woman of Valor: Margaret Sanger and the Birth Control Movement in America. New York: Simon & Schuster
15. Coverdale JH, Bayer TL, McCullough LB, Chervenak FA. 1993. Respecting the autonomy of chronic mentally ill women in decisions about contraception. Hosp. Commun. Psychiatry 44:671-74
16. Cowley G, Miller S. 1995. Norplant backlash: is it dangerous, or are lawyers exploiting it? Newsweek, Nov. 27, p. 52
17. Croll E, Davin D, Kane P. 1985. China's One-Child Family Policy. New York: St. Martin's Press
18. Feringa B, Iden S, Rosenfiejd A. 1992. Norplant: potential for coercion. In Norplant and Poor Women, ed. SE Samuels, MD Smith, pp. 54-56. Menlo Park, CA: Henry J. Kaiser Found.
19. Figureroa-Perea JG. 1994. The introduction of new methods of contraception: ethical perspectives. Reprod. Health Matters 3:13-19
20. Forrest JD, Kaeser L. 1993. Questions of balance: issues emerging from the introduction of the hormonal implant. Fam. Plan. Perspect. 25:127-32
21. Frost JJ. 1994. The availability and accessibility of the contraceptive implant from family planning agencies in the United States, 1991-1992. Fam. Plan. Perspect. 26:4-10
22. Garza-Flores J, Cravioto MC, Perez-Palacios G. 1994. Contraceptive research development: injectables. See Ref. 61a, pp. 53-68
23. Gordon L. 1981. Women's Right: Birth Control in America, pp. 95-115. New York: Penguin
24. Grant NJ. 1992. The Selling of Contraception: The Dalkon Shield Case, Sexuality, and Women's Autonomy, pp. 37-69. Columbus: Ohio State Univ. Press
25. Gwatkin DR. 1979. Political will and family planning: the implications of India's family planning experience. Popul. Dev. Rev. 5(1):29-59
26. Hardy E. 1996. Long-acting contraception in Brazil and the Dominican Republic. Fam. Plan. Perspect. 26:206-16
27. Harkavy O. 1995. Curbing Population Growth: An Insider's Perspective on the Population Movement. New York: Plenum
28. International Conference on Population and Development. 1994. Program of action. March 1995. Popul. Dev. Rev. 21(1):187-213; 21(2):437-61
29. International Conference on Population and Development. 1994. Program of action. March 1995. Popul. Dev. Rev. 21(1):187-213; 21(2):437-61
30. Isaacs SL. 1995. Incentives, population policy, and reproductive rights: ethical issues. Stud. Fam. Plan. 26:363-67
31. Jones E, Forrest JD. 1985. Teenage pregnancy in developed countries: determinants and policy implications. Fam. Plan. Perspect. 17:53-63
32. Kaeser L. 1994. Public funding and policies for provision of the contraceptive implant, fiscal year 1992. Fam. Plan. Perspect. 26:11-16
33. Macklin R. 1996. Cultural difference and long-acting contraception. In Coerced Contraception? Moral and Policy Challenges of Long-Acting Birth Control, ed. EH Moskowitz, BJ Jennings, pp. 173-91. Washington, DC: Georgetown Univ. Press
34. Macro International Inc. 1995. Indonesia Demographic and Health Survey 1994. Calverton, MD: Macro Int. Inc.
35. Mauldin WP, Segal SJ. 1994. IUD use throughout the world: past, present, and future. Proc. Int. Conf. IUDs, 4th, ed. WC Bardin, DR Mishell Jr, pp. 1-10. Boston: Butterworth-Heinemann
36. Mertus J, Heller S. 1992. Norplant meet the new eugenicists: the impermissibility of coerced contraception. St. Louis Univ. Public Law Rev. 11:359-83
37. Moskowitz EH, Jennings B. 1996. Directive counseling on long-acting contraception. Am. J. Public Health 86:787-90
38. Moskowitz EH, Jennings B, Callahan D. 1995. Long-acting contraception: ethical guidance for policymakers and health care providers. Hastings Cent. Rep. 25(1) (Suppl.):S1-8). Reprinted in Ref. 32, pp. 3-19
39. Nocera J. 1995. Fatal litigation. Fortune Oct. 16:60-82
40. Pachauri S. 1995. Defining a reproductive health package for India: a proposed framework. In The Population Council Regional Work. Pap., 4:7-66. New Delhi: Popul. Counc.
41. Pearce TO. 1996. Ethical issues in the importation of long-acting contraceptives to Nigeria. In Coerced Contraception? Moral and Policy Challenges of Long-Acting Birth Control, ed. EH Moskowitz, BJ Jennings, pp. 192-205. Washington, DC: Georgetown Univ. Press
42. Pearson CA. 1995. National Women's Network and the U.S. FDA: two decades of activism. Reprod. Health Matters 6:132-41
43. Peuple v. Johnson, No. 29390 (Cal. Super. Ct. Tulare County 1990)
44. Planned Parenthood Federation of America. 1991. Sexuality and reproductive behavior among U.S. teens. Fact Sheet. Feb.
45. Polaneczky M, Slap G, Forke C, Rappaport A, Sondheimre S. 1994. The use of Levenorgestrel implants (Norplant) for contraception in adolescent mothers. N. Engl. J. Med. 331:1201-6
46. Pollack AE. 1994. One hundred and seventy million sterilizations later: what we know and what we wish to know. See Ref. 61a, pp. 215-32
47. Population Council, New York. 1994. Letter, with Vaccine Statement attached, to the Women's Global Network for Reproductive Rights, The Netherlands, June 28
48. Population Council. 1993. 1992 Indonesia Norplant User-Dynamics Study. Asia Near East Operations Research and Technical Assistance Project, pp. 5, 28. New York: The Popul. Counc.
49. Powderly KE. 1994. Contraceptive policy and ethics: lessons from American history. See Ref. 21, pp. 23-33
50. Reilly P. 1991. The Surgical Solution. Baltimore: Johns Hopkins Univ. Press.
51. Relf v. Weinberger. 1974. 386 Fed. Suppl. 1384. DC. District Ct.
52. Richter J. 1993. Vaccination against Pregnancy: Miracle or Menace? Buko Pharma-Kampagne/Health Action International-Europe, Bielefeld
53. Robertson JA. 1994. Children of Choice: Freedom and the New Reproductive Technologies, Chapter 4. Princeton: Princeton Univ. Press
54. Seaman B. 1969. updated 1979. The Doctor's Case Against the Pill. New York: Dell
55. Segal SJ, Southam AL, Schafer KD, eds. 1964. Intrauterine Contraception: Proc. Int. Conf., 2nd. New York: Excerpta Media Found.
56. Sivin I. 1994. IUDs: a look to the future. See Ref. 61a, pp. 37-52
57. Spicehandler J. 1989. Norplant introduction: a management perspective. In Demographic and Programmatic Consequences of Contraceptive Innovations, ed. SJ Segal, AO Tsui, SM Rogers. New York: Plenum
58. State v. Carlton, No. CR90-1937 (Neb. County Ct. Lincoln County 1991).
59. Talk Paper. 1995. Issued by the U.S. Food and Drug Administration. Aug.
60. Thau R, Jackanicz T. 1994. Contraceptive rings: a user-controlled long-acting method for family planning. See Ref. 61a, pp. 107-20
61. Thau R, Robbins A. 1994. New implant systems for men and women. See Ref. 61a, pp. 91-106
62. United National Population Fund. 1994. Tech. Rep. No. 18: Contraceptive Use and Commodity Costs in Developing Countries 1994-2005. New York: UNFPA
63. 61a. Van Look PFA, Perez-Palacios G, eds. 1994. Contraceptive Research and Development 1984-1994: The Road from Mexico City to Cairo and Beyond. New York: Oxford Univ. Press
64. von Hertzon J, Van Look PFA. 1996. Research on new methods of emergency contraception. Fam. Plan. Perspect., March/April:52-57
65. Widyantoro N. 1994. The story of Norplant implants in Indonesia. Reprod. Health Matters 3:20-29
66. Women's Legal Defense Fund. 1992. Legislation and Litigation Involving Norplant, pp. 1-5. Washington, DC: Women's Legal Defense Fund
67. World Bank. 1995. India's Family Welfae Program: Toward A Reproductive and Child Health Approach. Washington, DC: World Bank, Popul. Hum. Resourc. Oper. Div., S. Asia Country Dep.
68. World Health Organization. 1990. Injectable Contraceptives. Geneva: WHO
69. World Health Organization. 1991. Creating Common Ground. Geneva: WHO, WHO/HRP/ITT/91.
70. World Health Organization. 1992. Fertility Regulating Vaccines. Geneva, Switzerland: WHO
71. World Health Organization. 1996. Special group on male contraceptive methods, contraceptive efficacy of testosterone-induced azoospermia and oligospermia in normal men. Fertil. Steril. 65:821-29